Refine your search results with filters

Specialty
Additional Specialty
Gender
Years of Experience
Level of Expertise

Last Updated: 10/19/2022

Looking for the best doctor for you?
Start Here
 
 
 
 
Learn about our expert tiers
Learn more
Learn about our doctor expertise tiers.
If you have a rare or serious condition, you may want to seek advice from the best doctor you can find.
In most cases, seeking advice from top-tier doctors may not be necessary.
Elite
  • Global leaders in their field
  • Publish in medical journals frequently
  • Speak at conferences
  • Participate in clinical trials
  • Likely to work with cutting edge treatments
  • Likely to hold leadership positions in their organization
Distinguished
  • Leaders in their field
  • Strong research portfolio
  • Likely to work with cutting edge treatments
  • Likely to be a leader in their field regionally
Advanced
  • Excellent at diagnosing and treating conditions.
  • Treat many patients and have extensive experience in their field.
  • May not publish, speak at conferences, or participate in clinical trials.
Experienced
  • Primarily treat patients rather than focus on research.
  • May be specialists or primary care physicians.
  • Have great experience in diagnosing and treating conditions.
  • Majority of doctors fall within this rating.
Find a second opinion
Find now
Location:
Enter a Location
Radius:
Global
6,066 doctors found
Sort By
Elite
Elite
Find a second opinion
Learn about our expert tiers
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Elite
Showing 1-20 of 6,066

Last Updated: 10/19/2022

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma and is an aggressive blood cancer that originates in the lymphatic system and affects B-lymphocytes, which is a type of white blood cell that helps to fight infection. Diffuse large B-cell lymphoma and can occur in one area of the body or throughout the body, and mainly occurs in individuals over the age of 60.  Diffuse large B-cell lymphoma is categorized by the following subtypes: T-cell/histiocyte-rich B-cell lymphoma – This subtype of diffuse large B-cell lymphoma has some scattered large and atypical B cells mixed with many normal T cells and histocytes (immune system cells). Primary diffuse large B-cell lymphoma of the central nervous system – This subtype of diffuse large B-cell lymphoma originates in either the brain or eye and can be a secondary development. Primary cutaneous diffuse large B-cell lymphoma, leg type – This subtype of diffuse large B-cell lymphoma is composed of large transformed B cells that create red or bluish-red tumors and can also involve the arms, trunk, buttocks, legs, or other areas. Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma of the elderly – This subtype of diffuse large B-cell lymphoma mainly occurs in patients over the age of 50 who test positive for the Epstein-Barr virus. Diffuse large B-cell lymphoma not otherwise specified (NOS) – This subtype of diffuse large B-cell lymphoma is for any that does not fall into one of the above classifications and represents 25-30% of diffuse large B-cell lymphoma in western countries. In addition to subtypes, diffuse large B-cell lymphoma is classified into the following stages: Stage I – The diffuse large B-cell lymphoma appears in one lymph node area or a cluster of nearby lymph nodes. Stage II – The diffuse large B-cell lymphoma appears in two lymph node area or has spread (metastasized) to one organ and nearby lymph nodes but is limited to an area of the body above or below the diaphragm.  Stage III – The diffuse large B-cell lymphoma appears in lymph nodes both above and below the diaphragm and may also appear in the spleen. Stage IV – This advanced stage diffuse large B-cell lymphoma appears in several areas of one or more organs and tissues and may also affect the liver, lungs, or bones. Diffuse large B-cell lymphoma is further classified by A or B to denote whether the patient is experiencing any significant symptoms (A), or if the patient has significant symptoms, such as unexplained weight loss, persistent fever, or severe night sweats (B).

Behind the List

MediFind is the industry authority on identifying the leading medical experts and latest research in order to help patients facing complex health challenges, including , make better health decisions. Leveraging our expertise in natural language processing and machine learning across thousands of diseases, we uncover physicians who are leading authorities on . MediFind identifies these experts using proprietary world-class models that assess over 2.5 million global doctors based on a range of variables, including research leadership, patient volume, peer standing, and connectedness to other experts. Learn more about our methodology by exploring how MediFind works.